Global Oncolytic Virus Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

According to APO Research, The global Oncolytic Virus market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oncolytic Virus is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oncolytic Virus is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Oncolytic Virus is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Oncolytic Virus is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Oncolytic Virus include Amgen and Shanghai Sunway Biotech etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oncolytic Virus, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Oncolytic Virus, also provides the sales of main regions and countries. Of the upcoming market potential for Oncolytic Virus, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oncolytic Virus sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oncolytic Virus market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oncolytic Virus sales, projected growth trends, production technology, application and end-user industry.


Oncolytic Virus Segment by Company

Amgen
Shanghai Sunway Biotech

Oncolytic Virus Segment by Type

Imlygic
Oncorine
Others

Oncolytic Virus Segment by Application

Melanoma
Other Cancers

Oncolytic Virus Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oncolytic Virus market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncolytic Virus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oncolytic Virus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Oncolytic Virus Market Size, 2020 VS 2024 VS 2031
1.3 Global Oncolytic Virus Market Size Estimates and Forecasts (2020-2031)
1.4 Global Oncolytic Virus Sales Estimates and Forecasts (2020-2031)
1.5 Global Oncolytic Virus Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Oncolytic Virus Market Dynamics
2.1 Oncolytic Virus Industry Trends
2.2 Oncolytic Virus Industry Drivers
2.3 Oncolytic Virus Industry Opportunities and Challenges
2.4 Oncolytic Virus Industry Restraints
3 Oncolytic Virus Market by Manufacturers
3.1 Global Oncolytic Virus Revenue by Manufacturers (2020-2025)
3.2 Global Oncolytic Virus Sales by Manufacturers (2020-2025)
3.3 Global Oncolytic Virus Average Sales Price by Manufacturers (2020-2025)
3.4 Global Oncolytic Virus Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Oncolytic Virus Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Oncolytic Virus Manufacturers, Product Type & Application
3.7 Global Oncolytic Virus Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Oncolytic Virus Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oncolytic Virus Players Market Share by Revenue in 2024
3.8.3 2024 Oncolytic Virus Tier 1, Tier 2, and Tier 3
4 Oncolytic Virus Market by Type
4.1 Oncolytic Virus Type Introduction
4.1.1 Imlygic
4.1.2 Oncorine
4.1.3 Others
4.2 Global Oncolytic Virus Sales by Type
4.2.1 Global Oncolytic Virus Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Oncolytic Virus Sales by Type (2020-2031)
4.2.3 Global Oncolytic Virus Sales Market Share by Type (2020-2031)
4.3 Global Oncolytic Virus Revenue by Type
4.3.1 Global Oncolytic Virus Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Oncolytic Virus Revenue by Type (2020-2031)
4.3.3 Global Oncolytic Virus Revenue Market Share by Type (2020-2031)
5 Oncolytic Virus Market by Application
5.1 Oncolytic Virus Application Introduction
5.1.1 Melanoma
5.1.2 Other Cancers
5.2 Global Oncolytic Virus Sales by Application
5.2.1 Global Oncolytic Virus Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Oncolytic Virus Sales by Application (2020-2031)
5.2.3 Global Oncolytic Virus Sales Market Share by Application (2020-2031)
5.3 Global Oncolytic Virus Revenue by Application
5.3.1 Global Oncolytic Virus Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Oncolytic Virus Revenue by Application (2020-2031)
5.3.3 Global Oncolytic Virus Revenue Market Share by Application (2020-2031)
6 Global Oncolytic Virus Sales by Region
6.1 Global Oncolytic Virus Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Oncolytic Virus Sales by Region (2020-2031)
6.2.1 Global Oncolytic Virus Sales by Region (2020-2025)
6.2.2 Global Oncolytic Virus Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Oncolytic Virus Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Oncolytic Virus Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Oncolytic Virus Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Oncolytic Virus Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Oncolytic Virus Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Oncolytic Virus Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Oncolytic Virus Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Oncolytic Virus Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Oncolytic Virus Revenue by Region
7.1 Global Oncolytic Virus Revenue by Region
7.1.1 Global Oncolytic Virus Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Oncolytic Virus Revenue by Region (2020-2025)
7.1.3 Global Oncolytic Virus Revenue by Region (2026-2031)
7.1.4 Global Oncolytic Virus Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Oncolytic Virus Revenue (2020-2031)
7.2.2 North America Oncolytic Virus Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Oncolytic Virus Revenue (2020-2031)
7.3.2 Europe Oncolytic Virus Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Oncolytic Virus Revenue (2020-2031)
7.4.2 Asia-Pacific Oncolytic Virus Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Oncolytic Virus Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Oncolytic Virus Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Amgen
8.1.1 Amgen Comapny Information
8.1.2 Amgen Business Overview
8.1.3 Amgen Oncolytic Virus Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Amgen Oncolytic Virus Product Portfolio
8.1.5 Amgen Recent Developments
8.2 Shanghai Sunway Biotech
8.2.1 Shanghai Sunway Biotech Comapny Information
8.2.2 Shanghai Sunway Biotech Business Overview
8.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Shanghai Sunway Biotech Oncolytic Virus Product Portfolio
8.2.5 Shanghai Sunway Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Oncolytic Virus Value Chain Analysis
9.1.1 Oncolytic Virus Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oncolytic Virus Production Mode & Process
9.2 Oncolytic Virus Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oncolytic Virus Distributors
9.2.3 Oncolytic Virus Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings